News

Samyang Holdings signed an MOU to co-develop a vaccine for COVID-19 with “mCureX (CEO: Hong Sun-woo),” a subsidiary of a “OliX Pharmaceuticals (CEO: Lee Dong-ki),” a pharmaceutical…
Read More...

Biogen and Eisai, Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for ADUHELM™ (aducanumab-avwa) as the first and only Alzheimer’s…
Read More...

Ascletis Pharma Inc. announces that China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for its drug candidate ASC42 to…
Read More...

Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, announced that it has submitted…
Read More...

Merck known as MSD outside the United States and Canada, announced it has completed the spinoff of Organon & Co. (Organon). “Today marks a significant milestone for both Merck…
Read More...

Bayer announced that it has entered into an agreement to acquire Noria Therapeutics Inc. (Noria) and PSMA Therapeutics Inc. Through this acquisition, Bayer will obtain exclusive rights…
Read More...

BioCryst Pharmaceuticals, Inc. announced that oral, once-daily ORLADEYO (berotralstat) is now available for patients with a prescription in Germany. ORLADEYO was approved by the…
Read More...

Moderna, Inc. announced that it has entered into an additional agreement with Lonza to support drug substance manufacturing for its global supply chain. The agreement will establish a…
Read More...

MorphoSys AG and Constellation Pharmaceuticals, Inc. announced that they have entered into a definitive agreement whereby MorphoSys will acquire Constellation for $34.00 per share in…
Read More...

Centivax Inc. announced that it has entered into a strategic partnership with the U.S. Naval Medical Research Center (NMRC) for Phase I clinical development of Centi-B9, Centivax's…
Read More...

Primordial Genetics a synthetic biology company developing enzymatic production systems for nucleic acids,  announced granting Arcturus Therapeutics Holdings Inc. a clinical-stage…
Read More...

GenScript Biotech Corporation along with its subsidiary, GenScript ProBio, and Ligand Pharmaceuticals Incorporated announced that they have entered into a strategic licensing agreement…
Read More...

Amgen and Kyowa Kirin Co., Ltd. announced an agreement to jointly develop and commercialize KHK4083, which is Kyowa Kirin's potential first-in-class, Phase 3-ready anti-OX40 fully human…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced that it has entered into an agreement with Thermo Fisher Scientific (NYSE: TMO)…
Read More...

POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits of precision radioligand therapy to cancer patients, announced today that the U.S.…
Read More...

Alkermes plc announced that the U.S. Food and Drug Administration (FDA) has approved LYBALVI (olanzapine and samidorphan) for the treatment of adults with schizophrenia and for the…
Read More...

NRx Pharmaceuticals announced it has filed an application with U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for ZYESAMI (Aviptadil-acetate), to…
Read More...

Amgen and Kyowa Kirin Co., Ltd. announced an agreement to jointly develop and commercialize KHK4083, which is Kyowa Kirin's potential first-in-class, Phase 3-ready anti-OX40 fully human…
Read More...

ADVANZ PHARMA Corp. Limited a specialty pharmaceutical company with a strategic focus on complex medicines in Europe, announced the completion of its acquisition by a subsidiary of…
Read More...

Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd., announced on May 26th that it had acquired a 50% stake in RosVivo Therapeutics Inc. ("Rosvivo"), an American new drug…
Read More...